Medical Supply Chains and Policy Options: The Data Challenge [September 16, 2020] [open pdf - 454KB]
From the Document: "The Coronavirus Disease 2019 (COVID-19) pandemic has revealed some areas in which the United States relies heavily on global supply chains. U.S. shortages of critical supplies of medical products have prompted congressional interest in better understanding U.S. import trends and domestic production capacity in certain industries considered essential to U.S. public health and national security. Some Members of Congress and the Trump Administration have sought ways to increase U.S. production of medical products, such as personal protective equipment (PPE) and pharmaceuticals, by providing economic incentives to firms and strengthening government procurement requirements to better prioritize domestically produced goods."
CRS In Focus, IF11648
Congressional Research Service: https://crsreports.congress.gov/